Unknown

Dataset Information

Development and characterization of formulations based on combinatorial potential of antivirals against genital herpes.


ABSTRACT: Herpes simplex virus type 2 (HSV-2) treatment faces challenges due to antiviral resistance and systemic side effects of oral therapies. Local delivery of antiviral agents, such as tenofovir (TDF) and zinc acetate dihydrate (ZAD), may offer improved efficacy and reduced systemic toxicity. This study's objective is to develop and evaluate local unit dose formulations of TDF and ZAD combination for local treatment of HSV-2 infection and exploring their individual and combinatory effects in vitro. The study involved the development of immediate-release film and pessary formulations containing TDF and ZAD. These formulations were characterized for physicochemical properties and in vitro drug release profiles. Cytotoxicity and antiviral activity assays were conducted to evaluate the individual a

SUBMITTER: Gaikwad M 

PROVIDER: S-EPMC11919951 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature